SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Montilla, C
Right arrow Articles by Alarcón-Segovia, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montilla, C
Right arrow Articles by Alarcón-Segovia, D
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anetoderma in systemic lupus erythematosus: relationship to antiphospholipid antibodies

C Montilla

Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico

D Alarcón-Segovia

Instituto Nacional de la Nutrici ón Salvador Zubirán, Vasco de Quiroga 15, 14000 Mexico D.F., Mexico. Tel: (+ 525) 573 1127; Fax (+ 525) 513 2926; Department of Immunology and Rheumatology, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico

Anetoderma is an elastolytic disorder where multiple patches of slack skin are formed.

Twelve patients with anetoderma associated with systemic lupus erythematous have been described, all in the dermatological literature. Recently, a role for antiphospholipid antibodies has been proposed with microthromboses as its pathogenic mechanism.

We present herein a 20-year-old female patient who developed anetoderma soon after sun exposure. She was found to have a false positive VDRL and gradually developed other manifestations of SLE, including interstitial cystitis. She has had repeatedly positive antiphospholipid antibodies.

Although there are patients who may have a primary form, diagnosis of anetoderma should trigger a search for SLE and/or antiphospholipid antibodies.

Key Words: systemic lupus erythematosus • anetoderma • antiphospholipid antibodies • elastic fibers

Lupus, Vol. 9, No. 7, 545-547 (2000)
DOI: 10.1177/096120330000900712
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
J M Sabio, J Tercedor, E Massare, J Jimenez-Alonso, and 'Grupo Lupus Virgen de las Nieves'
Letter to the Editor
Lupus, October 1, 2004; 13(10): 826 - 827.
[PDF]

Home page
 LupusHome page
E Hodak, H Feuerman, Y Molad, Y Monselise, and M David
Primary anetoderma: a cutaneous sign of antiphospholipid antibodies
Lupus, July 1, 2003; 12(7): 564 - 568.
[Abstract] [PDF]

Home page
 LupusHome page
J-E Herrero-Gonzalez and C Herrero-Mateu
Primary anetoderma associated with primary Sjogren's syndrome
Lupus, February 1, 2002; 11(2): 124 - 126.
[Abstract] [PDF]


Advertisement